Dr. Novick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Health Plaza
Randolph, NJ 07869Phone+1 862-778-2722
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
- New York University School of MedicineClass of 1995
Publications & Presentations
PubMed
- 148 citationsPhase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia.Susan O'Brien, Charles C. Cunningham, Anatoliy K. Golenkov, Anna G. Turkina, Steven Novick
Journal of Clinical Oncology. 2005-10-20 - 107 citationsPhase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Ac...Guido Marcucci, Wendy Stock, Guowei Dai, Rebecca B. Klisovic, Shujun Liu
Journal of Clinical Oncology. 2005-05-20 - 14 citationsPharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies.Robert Wieder, Steven C Novick, Bruce W. Hollis, Margarette Bryan, Suzanne Chanel
Investigational New Drugs. 2003-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: